SCHEMBL3233140

SCHEMBL3233140

C=CCCCCCCCC.C=CCCCCCCCC(=O)O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.80
ABCC4 O15439 1/20 0.80
PPARG P37231 9/20 0.71
PPARD Q03181 9/20 0.71
PPARA Q07869 9/20 0.71
PTPN1 P18031 5/20 0.71
FABP4 P15090 4/20 0.71
TERT O14746 3/20 0.71
HSD17B10 Q99714 3/20 0.71
TDP1 Q9NUW8 3/20 0.71
BLM P54132 2/20 0.71
ALOX15 P16050 2/20 0.71
FABP5 Q01469 2/20 0.71
KMT2A Q03164 2/20 0.71
GMNN O75496 1/20 0.71
USP2 O75604 1/20 0.71
LMNA P02545 1/20 0.71
CYP1A2 P05177 1/20 0.71
POLB P06746 1/20 0.71
CYP2C9 P11712 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexanoate SCHEMBL29051050 1.00 MAPT (0.80) MAPTABCC4PPARGPPARDPPARA
Hexanoate SCHEMBL17962235 1.00 MAPT (0.80) MAPTABCC4PPARGPPARDPPARA
Stearic Acid SCHEMBL4022742 1.00 MAPT (0.80) MAPTABCC4PPARGPPARDPPARA
Hexanoate SCHEMBL16418126 1.00 MAPT (0.80) MAPTABCC4PPARGPPARDPPARA
Palmitic Acid SCHEMBL15537187 1.00 MAPT (0.80) MAPTABCC4PPARGPPARDPPARA
Behenic Acid SCHEMBL19945952 1.00 MAPT (0.80) MAPTABCC4PPARGPPARDPPARA
Hexanoate SCHEMBL413538 1.00 MAPT (0.80) MAPTABCC4PPARGPPARDPPARA
Undecylenic Acid SCHEMBL10818405 1.00 MAPT (0.80) MAPTABCC4PPARGPPARDPPARA
Heptanoate SCHEMBL4053087 1.00 MAPT (0.80) MAPTABCC4PPARGPPARDPPARA
Octanoic Acid SCHEMBL28943415 1.00 MAPT (0.80) MAPTABCC4PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190284152-A1 Maleinated Derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2019-09-19 US disclosed
CN-109843976-A The polyamide and its manufacturing method obtained by renewable source 埃莱万斯可再生能源科学股份有限公司 2019-06-04 CN disclosed
US-10294210-B2 Maleinated derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2019-05-21 US disclosed
US-20180111912-A1 Maleinated Derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2018-04-26 US disclosed
US-9896424-B2 Methods of making sulfurized derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2018-02-20 US disclosed
US-9738618-B2 Malienated derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2017-08-22 US disclosed
US-20160355492-A1 Methods of Making Sulfurized Derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2016-12-08 US disclosed
CN-103562362-B The monomer of functionalization 艾勒旺斯可再生科学公司 2016-09-14 CN disclosed
US-9334347-B2 Functionalized monomers and polymers ELEVANCE RENEWABLE SCIENCES, INC. (US) 2016-05-10 US disclosed
US-20140357539-A1 FUNCTIONALIZED MONOMERS AND POLYMERS WILMAR TRADING PTE LTD (SG) 2014-12-04 US disclosed
US-20120277133-A1 FUNCTIONALIZED POLYMERS ELEVANCE RENEWABLE SCIENCES, INC. 2012-11-01 US disclosed
US-20120264662-A1 FUNCTIONALIZED MONOMERS ELEVANCE RENEWABLE SCIENCES 2012-10-18 US disclosed
US-20120264664-A1 MALIENATED DERIVATIVES WILMAR TRADING PTE LTD (SG) 2012-10-18 US disclosed
US-20120245063-A1 FUNCTIONALIZED MONOMERS AND POLYMERS WILMAR TRADING PTE LTD (SG) 2012-09-27 US disclosed
WO-2012128788-A1 FUNCTIONALIZED MONOMERS AND POLYMERS ELEVANCE RENEWABLE SCIENCES, INC. (US) 2012-09-27 WO disclosed
WO-2012129482-A2 FUNCTIONALIZED MONOMERS ELEVANCE RENEWABLE SCIENCES (US) 2012-09-27 WO disclosed
WO-2012129490-A2 FUNCTIONALIZED POLYMERS ELEVANCE RENEWABLE SCIENCES (US) 2012-09-27 WO disclosed
WO-2012129479-A2 MALIENATED DERIVATIVES ELEVANCE RENEWABLE SCIENCES (US) 2012-09-27 WO disclosed
WO-2012129477-A1 FUNCTIONALIZED MONOMERS ELEVANCE RENEWABLE SCIENCES (US) 2012-09-27 WO disclosed
WO-2010010290-A1 CATALYTIC COMPOSITIONS FOR THE METATHESIS OF UNSATURATED FATS WITH OLEFINS, AND METATHESIS METHODS USING SAME RHODIA OPERATIONS (FR) 2010-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120277133-A1 FUNCTIONALIZED POLYMERS PARG, PUF60, ADH1C MAPT 655/4885ABCC4 4703/4885PPARG 1200/4885
US-20120264662-A1 FUNCTIONALIZED MONOMERS MEP1A, MLEC, ADH1A MAPT 1894/4885ABCC4 4754/4885PPARG 2125/4885
US-20180111912-A1 Maleinated Derivatives SMOX, SRM, PADI2 MAPT 1493/4885ABCC4 4721/4885PPARG 1494/4885
US-20120245063-A1 FUNCTIONALIZED MONOMERS AND POLYMERS PUF60, FGB, MSN MAPT 1386/4885ABCC4 4137/4885PPARG 704/4885
US-20190284152-A1 Maleinated Derivatives SMOX, SRM, PADI2 MAPT 1493/4885ABCC4 4721/4885PPARG 1494/4885
US-20160355492-A1 Methods of Making Sulfurized Derivatives GPX4, CBS, ESD MAPT 2790/4885ABCC4 3287/4885PPARG 1214/4885
US-10294210-B2 Maleinated derivatives SMOX, SRM, PADI2 MAPT 1538/4885ABCC4 4724/4885PPARG 1473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.